Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Senti Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.56 | -$0.56 | -$0.56 |
| Q2 2025 | 2 | -$1.25 | -$0.55 | -$0.90 |
| Q3 2025 | 1 | -$0.88 | -$0.88 | -$0.88 |
| Q4 2025 | 1 | -$0.81 | -$0.81 | -$0.81 |
Senti Biosciences, Inc. Earnings Date And Information
Senti Biosciences, Inc. last posted its earnings results on Tuesday, May 6th, 2025. The company reported $-1.41 earnings per share for the quarter, missing analysts' consensus estimates of $-0.58 by $0.83. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Senti Biosciences, Inc. has generated $-11 earnings per share over the last year ($-11.49 diluted earnings per share) and currently has a price-to-earnings ratio of -0.39. Senti Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based on prior year's report dates.
Senti Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/06/2025 | Q1 2025 | -$0.58 | -$1.41 | -0.83 | $1.30 M | $0 |
| 03/20/2025 | Q4 2024 | -$3.13 | -$0.13 | 3 | $2.80 M | $5.86 M |
| 11/14/2024 | Q3 2024 | N/A | -$6.31 | N/A | $0 | $0 |
| 08/13/2024 | Q2 2024 | N/A | -$2.45 | N/A | $0 | $0 |
| 05/09/2024 | Q1 2024 | N/A | -$2.65 | N/A | $3.44 M | $0 |
| 04/26/2024 | Q4 2023 | N/A | -$4.16 | N/A | $618.50 K | $333.00 K |
| 11/13/2023 | Q3 2023 | N/A | -$3.36 | N/A | $668.50 K | $255.00 K |
| 08/11/2023 | Q2 2023 | -$4.80 | -$4.22 | 0.58 | $500.00 K | $937.00 K |
| 05/09/2023 | Q1 2023 | -$4.80 | -$4.25 | 0.55 | $466.67 K | $1.04 M |
| 03/22/2023 | Q4 2022 | -$4.70 | -$4.16 | 0.54 | $1.51 M | $59.00 K |
| 11/10/2022 | Q3 2022 | -$5.20 | -$3.83 | 1.37 | $929.00 K | $1.77 M |
| 08/15/2022 | Q2 2022 | N/A | -$2.65 | N/A | N/A | $1.11 M |
| 05/16/2022 | Q1 2022 | N/A | -$2.70 | N/A | N/A | $854.00 K |
| 03/07/2022 | Q4 2021 | N/A | -$2.50 | N/A | N/A | $543.00 K |
| 11/10/2021 | Q3 2021 | N/A | -$2.61 | N/A | N/A | $926.00 K |
| 08/06/2021 | Q2 2021 | N/A | -$2.75 | N/A | N/A | $778.00 K |
| 07/02/2021 | Q1 2021 | N/A | -$0.00 | N/A | N/A | $72.00 K |
| 12/30/2020 | Q4 2020 | N/A | -$0.75 | N/A | N/A | $2.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Senti Biosciences, Inc. Earnings: FAQ's
Senti Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 13th, 2025 based offlast year's report dates.
The conference call for Senti Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Senti Biosciences, Inc.'s latest earnings report can be read online.
Senti Biosciences, Inc. (:SNTI) has a recorded net income of $-52,790,000.Senti Biosciences, Inc. has generated $-11.49 earnings per share over the last four quarters.
Senti Biosciences, Inc. (:SNTI) has a price-to-earnings ratio of -0.39 and price/earnings-to-growth ratio is -0.04.